Articles From: Safeway Inc. Announces Extension of Offer to Purchase Senior Notes Due 2019, 2020 and 2021 to Saint Luke’s Enters Into Agreement with Humana


http://media.marketwire.com/attachments/201304/144900_SafewayforImmediateReleaseLogo.JPG http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1167539&ProfileId=051205&sourceType=1 PLEASANTON, CA --
Sign-up for Safeway Inc. Announces Extension of Offer to Purchase Senior Notes Due 2019, 2020 and 2021 investment picks
PLEASANTON, Calif.
Sign-up for Safeway Inc. Board Of Directors Declares Quarterly Dividend investment picks
2014/12/3
GROSSE POINTE FARMS, Mich.
Sign-up for Saga Communications, Inc. Declares Quarterly Cash Dividend of $0.20 per Share and Special Cash Dividend of $1.20 per Share investment picks
2014/11/7
Net Operating Revenue Increased 4.4% GROSSE POINTE FARMS, Mich.
Sign-up for Saga Communications, Inc. Reports 3rd Quarter Results investment picks
2014/11/18
Aspidistra Software , which specialises in creating B2B ecommerce software for Sage systems, has turned to cloud company iomart for secure private cloud to support its rapid growth.
Sign-up for Sage Ecommerce Software Company Chooses iomart Private Cloud investment picks
2014/11/10
Hundreds of UK Businesses Abandon Sage in Favour of NetSuite Cloud to Drive Business Growth DWA Among the Hundreds of Companies That Has Already Reached the End of the Line with Sage LONDON , Nov.
Sign-up for Sage Lines Terminate At NetSuite investment picks
CAMBRIDGE, Mass., Dec.
Sign-up for SAGE Therapeutics Added to NASDAQ Biotechnology Index investment picks
CAMBRIDGE, Mass., Oct.
Sign-up for SAGE Therapeutics Initiates Exploratory Study of SAGE-547 in Essential Tremor investment picks
CAMBRIDGE, Mass., Jan.
Sign-up for SAGE Therapeutics Initiates Phase 2a Trial of SAGE-547 in Postpartum Depression investment picks
SAGE-547 Met Primary and Secondary Efficacy and Safety Endpoint Targets CAMBRIDGE, Mass., Nov.
Sign-up for SAGE Therapeutics Reports Positive Top-Line Phase 2 Data of SAGE-547 in Patients With Super-Refractory Status Epilepticus investment picks
CAMBRIDGE, Mass., Nov.
Sign-up for SAGE Therapeutics Reports Third Quarter 2014 Results investment picks
Greater Than 70 Percent Response Rate Observed in Two Patient Groups Data Reinforce Clinical Activity and Safety Profile Demonstrated by SAGE-547 Phase 3 Pivotal Trial Expected to Begin by Mid-2015 CAMBRIDGE, Mass., Jan.
Sign-up for SAGE Therapeutics Reports Updated Data From Ongoing Clinical Trial and Emergency Use Program of SAGE-547 in Patients With Super-Refractory Status Epilepticus investment picks
CAMBRIDGE, Mass., Jan.
Sign-up for SAGE Therapeutics to Present at 33rd Annual J.P. Morgan Healthcare Conference investment picks
CAMBRIDGE, Mass., Nov.
Sign-up for SAGE to Present at Credit Suisse 23rd Annual Healthcare Conference investment picks
SCHAUMBURG, Ill., Dec.
Sign-up for Sagent Pharmaceuticals Announces the Launch of Colistimethate for Injection, USP investment picks
SCHAUMBURG, Ill., Nov.
Sign-up for Sagent Pharmaceuticals Reports Third Quarter 2014 Financial Results investment picks
SCHAUMBURG, Ill., Oct.
Sign-up for Sagent Pharmaceuticals Sets Date and Time for Release of Third Quarter 2014 Financial Results investment picks
SCHAUMBURG, Ill., Jan.
Sign-up for Sagent Pharmaceuticals to Present at 33rd Annual J.P. Morgan Healthcare Conference investment picks
http://media.marketwire.com/attachments/201301/116853_SaiaInc.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1154238&ProfileId=051205&sourceType=1 JOHNS CREEK, GA --
Sign-up for Saia Reports Record Third Quarter Earnings per Share of $0.64 investment picks
http://media.marketwire.com/attachments/201301/116853_SaiaInc.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1168174&ProfileId=051205&sourceType=1 JOHNS CREEK, GA --
Sign-up for Saia to Announce Fourth Quarter 2014 Results on January 30, 2015 investment picks
- Total revenues: $1,004 million ($993 million excluding revenues performed by former parent) - Operating income: $63 million, 6.3% of revenues excluding revenues performed by former parent - Diluted earnings per share: $0.77 - Cash flows provided by operating activities: $82 million - Quarterly dividend: $0.28 per share dividend declared; payable on January 30, 2015 MCLEAN, Va.
Sign-up for SAIC Announces Third Quarter of Fiscal Year 2015 Results investment picks
Over the next five years, company will support the Hume Center's Education Program and Intelligence Community Center for Academic Excellence MCLEAN, Va.
Sign-up for SAIC Donates $750,000 to Virginia Tech's Hume Center for National Security and Technology investment picks
2015/1/7
By Ian Walker LONDON--J Sainsbury PLC (SBRY.LN) Wednesday reported a 1.7% fall in same-store sales, excluding fuel, for the 14 weeks ended Jan.
Sign-up for Sainsbury 3Q Comparable Sales Down 1.7%; Sees 4Q Similar to 1st Half investment picks
2015/1/13
By Ian Walker LONDON--J Sainsbury PLC (SBRY.LN), the U.K. number two supermarket by market share, said Tuesday it will cut 500 jobs as part of its previously announced effort to save 500 million pounds ($757.5 million). Following a review of central costs and structures, Sainsbury said it plans to streamline its central divisions and bring the supermarkets and convenience businesses together.
Sign-up for Sainsbury to Cut 500 Jobs investment picks
2015/1/7
By Carla Mozee, MarketWatch LONDON (MarketWatch) -- U.K. stocks climbed Wednesday, with J Sainsbury PLC shares gaining after a trading update from the supermarket-chain operator.
Sign-up for Sainsbury, Aggreko lead gains for FTSE 100 investment picks
2015/1/13
By Ian Walker LONDON--J.
Sign-up for Sainsbury's Jumps to Number 2 Spot - Kantar investment picks
Saint Luke’s Health System, an integrated hospital and physician network with locations throughout the Kansas City region, and Humana Inc. (NYSE: HUM), a leading health and well-being company, announced today an agreement through which Humana will offer a new health insurance plan to Missourians purchasing insurance through the Missouri Health Insurance Marketplace, also known as an exchange.
Sign-up for Saint Luke’s Enters Into Agreement with Humana investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: Safeway Inc. Announces Extension of Offer to Purchase Senior Notes Due 2019, 2020 and 2021 to Saint Luke’s Enters Into Agreement with Humana
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent